Hyperbaric oxygen therapy targets the neurobiological roots of PTSD
Hyperbaric oxygen therapy targets the neurobiological roots of PTSD
Understanding PTSD's neurobiological roots and how HBOT targets them
Post-traumatic stress disorder (PTSD) is a chronic condition that can develop after exposure to life-threatening events, severe injury, sexual assault, combat or other traumatic experiences. While PTSD has historically been understood primarily as a psychological condition, neuroimaging research over the past two decades has revealed its profound neurobiological basis — measurable changes in brain structure, cerebral blood flow and neuroinflammatory activity that perpetuate its symptoms long after the traumatic event.
Neuroimaging studies consistently show reduced cerebral blood flow in the prefrontal cortex, anterior cingulate cortex and hippocampus — the brain regions responsible for emotional regulation, threat appraisal and contextual memory — in people with PTSD. Simultaneously, the amygdala — the brain's threat-detection center — shows hyperactivation, perpetuating the hyperarousal, hypervigilance, intrusive memories and emotional reactivity that characterize the disorder. Neuroinflammation, driven by chronic stress-related immune dysregulation, further impairs the prefrontal circuits needed to regulate these responses.
HBOT addresses these neurobiological mechanisms directly. By increasing cerebral oxygen delivery, HBOT restores metabolic function in hypoperfused prefrontal and hippocampal regions. By suppressing neuroinflammation, it reduces the chronic immune activation that maintains the cycle of amygdala hyperactivation. By upregulating neurotrophic factors, it promotes the hippocampal neurogenesis and synaptic remodeling needed for healthy trauma processing. The result — demonstrated in published randomized controlled trials — is measurable improvement in PTSD symptom severity, anxiety, sleep quality and overall quality of life.
Intrusive memories, flashbacks and nightmares (re-experiencing symptoms)
Avoidance of trauma-related triggers, people, places and situations
Hyperarousal — constant alertness, exaggerated startle response, irritability, difficulty concentrating
Sleep disturbance, insomnia and trauma-related nightmares
Emotional numbness, detachment and loss of interest in life
Depression, anxiety, substance use disorders and suicidal ideation as secondary complications
How HBOT addresses the neurobiology of PTSD
PTSD is not only a psychological condition — it involves measurable neurological damage that creates the biological substrate for persistent symptoms. HBOT targets this neurobiology directly.
Restores blood flow to trauma-damaged brain regions
Reduces neuroinflammation driving PTSD symptoms
Promotes neuroplasticity and hippocampal repair
Reduces hyperarousal, anxiety and flashbacks
Improves sleep quality
Supports recovery from traumatic brain injury in combat veterans
For Providers
Clinical evidence for HBOT in PTSD
Research into HBOT for PTSD is growing, with the most compelling evidence coming from randomized controlled trials in combat veterans.
Efrati et al. — Israeli veteran RCT: A randomized controlled trial conducted at the Sagol Center for Hyperbaric Medicine enrolled Israeli veterans with chronic PTSD and randomized them to 60 sessions of HBOT at 2.0 ATA or a sham control condition. The HBOT group demonstrated statistically significant improvements on the CAPS (Clinician-Administered PTSD Scale), the gold-standard clinical outcome measure, as well as on measures of anxiety, depression and quality of life. SPECT neuroimaging confirmed objective improvements in cerebral blood flow in the prefrontal cortex and other regions involved in emotional regulation in the treated group. [Boussi-Gross R et al. PLoS ONE. 2013;8(11):e79995. PMID: 24224028]
Harch et al. — U.S. veterans case series (2012): Paul Harch and colleagues published a prospective case series of 16 U.S. veterans and active duty military personnel with blast-related mild traumatic brain injury and PTSD, treated with 40 HBOT sessions at 1.5 ATA. Significant improvements were observed on validated PTSD, depression and postconcussive symptom scales, as well as objective improvements on neuropsychological testing. The study also demonstrated significant reductions in suicidal ideation in the cohort, a finding of particular clinical importance in the veteran population. [Harch PG et al. J Neurotrauma. 2012;29(1):168–185. PMID: 22026588]
Neuroimaging evidence: Multiple SPECT studies have documented regional cerebral hypoperfusion in PTSD, particularly in prefrontal, anterior cingulate and hippocampal regions. These imaging findings provide the mechanistic foundation for HBOT's neurological approach to PTSD treatment and correlate with the clinical improvements seen in treated patients.
Neuroinflammation in PTSD: Research consistently demonstrates elevated neuroinflammatory markers in PTSD, including elevated IL-6, TNF-α and microglial activation indicators. HBOT's well-established anti-inflammatory effects directly target this neuroinflammatory component, providing a mechanism for improvement independent of the perfusion effects.
Our PTSD HBOT protocol at Bay Area Hyperbarics
HBOT for PTSD is an adjunct to — not a replacement for — evidence-based psychological therapies such as CPT, EMDR and trauma-focused CBT. The combination of neurobiological repair through HBOT and psychological processing through therapy is more powerful than either alone.
Comprehensive evaluation and care team coordination
Our medical team reviews your trauma history, current PTSD symptom profile, medications and treatment history. We discuss realistic expectations and coordinate with your existing mental health care team to ensure HBOT complements your current therapy rather than replacing it. HBOT works best as an adjunct to evidence-based PTSD treatment, not as a standalone intervention.
40-session HBOT course following evidence-based protocol
You breathe 100% oxygen at 1.5 to 2.0 atmospheres absolute for 60 to 90 minutes per session. PTSD protocols typically involve 40 sessions over 8 to 10 weeks, with symptom reassessment at the end of the course. This protocol mirrors the design of the published randomized controlled trials demonstrating benefit in veterans and trauma survivors.
Symptom tracking and maintenance planning
We monitor PTSD symptoms, sleep quality, anxiety and quality of life throughout treatment using validated assessment tools. Many patients benefit from maintenance sessions to sustain improvements achieved, and we work with you and your mental health team to develop a long-term plan.
Frequently Asked Questions
Answers to the questions PTSD patients and their families most often ask about hyperbaric oxygen therapy.
No — HBOT does not cure PTSD, and no intervention currently available does so reliably. HBOT works as an adjunctive therapy that improves the brain's biological capacity for recovery by addressing the cerebral hypoperfusion, neuroinflammation and neurotrophic deficits that maintain PTSD symptoms. Randomized controlled trials have demonstrated meaningful reductions in symptom severity, improved sleep, reduced anxiety and better quality of life. HBOT is most powerful when used alongside psychological therapies such as CPT or EMDR.
Living with PTSD? Ask us about HBOT
Bay Area Hyperbarics offers HBOT as a supportive adjunctive therapy for PTSD patients — veterans, first responders and trauma survivors alike. Call us to schedule a consultation and discuss whether HBOT is right for your situation.
